Summary
First Trust Nasdaq Pharmaceuticals ETF is an ETF - a fund traded on an exchange like a stock - run by First Trust. Positions inside: 51. The ten largest make up 56% of the fund.
- Yearly costs
- 0.60%
- Fund size
- $1.11B
- Positions
- 51
- Dividend yield
- 0.70%
- Running since
- 2016
What speaks for it
- A large fund with $1.11B under management.
- Easy to buy and sell: about $20.3M changes hands a day.
- Average yearly growth over the last ten years: 8.1%.
- It has been running since 2016.
What to watch
- The ten largest positions make up 56% of the fund, so its result rests on a few names.
- 100% of the fund is in one sector (Healthcare).
- 97% of the fund is in one country (United States).
- Costs of 0.60% a year are above the middle of comparable funds (0.44%).
A fund has no Bulios Score and no Fair Price of its own - both are computed from the results of a single company. This page shows what is inside the fund and what it costs instead.
Price
Performance
- 1 month
- +1.2%
- 3 months
- +9.4%
- This year
- +26%
- 1 year
- +41%
- 3 years
- +66%
- 5 years
- +60%
- 10 years
- +118%
- Avg. market cap
- $247.6B
- P/E
- 28.9x
- Forward P/E
- 17.5x
- P/S
- 4.7x
- P/B
- 4.5x
- P/FCF
- 19.3x
- EV/EBITDA
- 19.4x
- Dividend yield
- 1.50%
- ROIC
- 12.3%
- ROE
- 29.1%
- Gross margin
- 74.0%
- Operating margin
- -109.0%
- Net margin
- -12.1%
- Payout ratio
- 43.2%
- Net debt/EBITDA
- 4.6x
- Beta
- 0.46
Weighted average of the 50 largest companies, which make up 100% of the fund. Banks and insurers are left out of the gross margin, the ROIC and the EBITDA figures.
What is inside?
Concentrated- 1 ABAbbVie ABBV 7.9%
- 2 LLEli Lilly LLY 7.7%
- 3 PFPfizer PFE 7.4%
- 4 MRMerck & Co. MRK 7.0%
- 5 JNJohnson & Johnson JNJ 6.8%
- 6 VTViatris VTRS 4.0%
- 7 BIBiogen BIIB 3.8%
- 8 GIGilead Sciences GILD 3.8%
- 9 ZTZoetis ZTS 3.7%
- 10 AMAmgen AMGN 3.6%
Positions in the fund: 51. The ten largest make up 56% of it.
Composition as of Oct 18, 2026.
Where is it spread?
One sector dominatesBy sector
- Healthcare 100%
By country
- United States 97%
- Ireland 2.9%
- United Kingdom 0.5%
- Other countries 0.06%
By company size
- Mega cap 33%
- Large cap 57%
- Mid cap 9.5%
By the company's market value: Mega cap from $200B, Large cap from $10B, Mid cap from $2B, Small cap from $300M, Micro cap below $300M.
Largest sector: Healthcare (100%). Largest country: United States (97%). Largest size group: Large cap (57%).
What does it cost me?
Expensive- A year from $10,000
- $60.00
- Over 20 years
- $2,873
From every $10,000 invested the fund takes $60.00 a year. You do not pay it separately - it is taken out of the fund's value. Over 20 years at 5% yearly growth that adds up to about $2,873.
How has it done?
Growing over the long run- A year on average, 10 years
- +8.1%
- Deepest drop
- -21%
- Yearly volatility
- 18%
Average yearly growth over the last ten years: 8.1%. Deepest drop in these years: 21% below the earlier high.
Does it pay dividends?
Yes, it pays out- Yield
- 0.70%
- Payments a year
- 4
- Last payment
- $0.01
Over the last 12 months it paid $0.29 per share, which is 0.70% of today's price. The last payment was $0.01 on Sep 24, 2026.
Is it easy to buy and sell?
Very easy- Traded a day
- $20.3M
- Shares a day
- 488K
On an average day about $20.3M of the fund changes hands.
How expensive are the companies inside?
Rather expensive- P/E of the companies inside
- 28.9
- Average Bulios Score
- 58 out of 100
Weight by Bulios Fair Price
- Undervalued 28%
- Fairly valued 22%
- Overvalued 50%
On average the companies inside trade for 28.9 times their yearly profit. By Fair Price, 50% of the rated weight comes out as overvalued.
Counted from its largest companies (50), which make up 100% of the fund. Each company counts by its weight. We use the metrics, the Bulios Score and the Fair Price of the companies themselves.
Similar funds
Funds that hold much of the same. The overlap says how much of their weight they share with this fund.
| Fund | Domicile | Size | 1-year change | Dividends | ||
|---|---|---|---|---|---|---|
PJ PJP Invesco Pharmaceuticals ETF | United States | 0.58% | $361.1M | +30% | Pays out | 55% |
IY IYH iShares U.S. Healthcare ETF | United States | 0.37% | $4.33B | +21% | Pays out | 48% |
VH VHT Vanguard Health Care ETF | United States | 0.09% | $21.7B | +20% | Pays out | 46% |
VH VHCIX Vanguard Health Care Index Fund Admiral Shares· mutual fund | United States | 0.09% | $21.7B | +20% | Pays out | 46% |
ZP ZPDH.DE State Street SPDR S&P U.S. Health Care Select Sector UCITS ETF (Acc) | Ireland | 0.15% | $619.4M | +28% | Reinvests | 46% |
IU IUHE.AS iShares S&P 500 Health Care Sector UCITS ETF | Ireland | 0.18% | $143.7M | +20% | Pays out | 46% |